Literature DB >> 16255342

Fatal unintentional overdose of diltiazem with antemortem and postmortem values.

F Lee Cantrell1, Saralyn R Williams.   

Abstract

BACKGROUND: Therapeutic errors involving calcium channel antagonists (CCA) resulting in death rarely have been reported in detail. We report a fatality from an unintentional overdose of sustained-release (SR) diltiazem including antemortem and postmortem blood concentrations. CASE REPORT: A 65-year-old man with aortic stenosis mistakenly took six tablets of diltiazem 360 mg SR. He developed symptoms of toxicity by 7 hours after ingestion. By 10 hours, he went to the emergency department. Despite a prolonged resuscitative attempt, the patient died 17 hours postingestion. An antemortem blood sample drawn 11.5 hours after ingestion was 2.9 mcg/mL. Postmortem gas chromatography of central blood revealed a diltiazem level of 6 mcg/mL and the peripheral blood sample measured 5 mcg/ mL.
CONCLUSION: This case suggests that an unintentional overdose with a CCA may be lethal if the patient's cardiovascular ability to compensate for the toxic effects is compromised.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16255342     DOI: 10.1081/clt-200068860

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  3 in total

Review 1.  Post-mortem clinical pharmacology.

Authors:  R E Ferner
Journal:  Br J Clin Pharmacol       Date:  2008-05-29       Impact factor: 4.335

2.  Cardiotoxic overdose treated with intravenous fat emulsion and high-dose insulin in the setting of hypertrophic cardiomyopathy.

Authors:  Samuel J Stellpflug; Sandy J Fritzlar; Jon B Cole; Kristin M Engebretsen; Joel S Holger
Journal:  J Med Toxicol       Date:  2011-06

3.  Circulatory Support with Venoarterial ECMO Unsuccessful in Aiding Endogenous Diltiazem Clearance after Overdose.

Authors:  Erin N Frazee; Sarah J Lee; Ejaaz A Kalimullah; Heather A Personett; Darlene R Nelson
Journal:  Case Rep Crit Care       Date:  2014-08-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.